Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer
Cells · 2025
DOI: 10.3390/cells14241948 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Thi Thuy Truong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Industry 4.0 Convergence Bionics Engineering, Department of Biomedical Engineering, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, Antioxidants, Epigenesis, Genetic, Signal Transduction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, The Global Joint Research Program funded by the Pukyong National University.
Abstract (Originalsprache)
Redox imbalance and epigenetic dysregulation, which both contribute to tumor initiation, survival, and resistance to therapy, are intimately linked to the progression of cancer. Reactive oxygen species (ROS) have two contrasting effects: at moderate concentrations, they promote angiogenesis and oncogenic signaling, whereas at high concentrations, they trigger apoptosis. Oxidative stress alters histone modifications, DNA methylation, and non-coding RNA (ncRNA) expression, reshaping the epigenetic landscape and supporting malignant phenotypes. Plant-derived antioxidants, including flavonoids, polyphenols, alkaloids, and terpenoids, act as dual modulators of cancer biology. They scavenge or regulate reactive oxygen species (ROS), restore redox balance, activate tumor suppressor pathways, inhibit oncogenic mechanisms, and reverse abnormal epigenetic marks. Compounds such as resveratrol, curcumin, epigallocatechin gallate (EGCG), quercetin, and sulforaphane modulate DNA methyltransferases (DNMTs), histone deacetylases (HDACs), and non-coding RNA networks, and can enhance chemotherapy and radiation therapy. Despite promising mechanisms, challenges remain in translational efficacy, optimal dosing, and bioavailability. This review emphasizes the potential of plant-derived antioxidants as precision oncology adjuncts and highlights the need for biomarker-guided strategies, nano-delivery systems, and clinical validation to fully realize their therapeutic benefits. Plant-derived antioxidants mitigate ROS-induced oncogenic signaling, as evidenced by in vitro and clinical models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Industry 4.0 Convergence Bionics Engineering, Department of Biomedical Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
- Weldon School of Biomedical Engineering, Purdue University, Indianapolis, IN 46202, USA.
- Smart Gym-Based Translational Research Center for Active Senior's Healthcare, Pukyong National University, Busan 48513, Republic of Korea.
- Digital Healthcare Research Center, Institute of Information Technology and Convergence, Pukyong National University, Busan 48513, Republic of Korea.
ORCID-Profile: Alka Ashok Singh, Soonhyuk Tak, Sungsoo Na, Junghwan Oh, Sudip Mondal
Förderung
- National Research Foundation of Korea
- The Global Joint Research Program funded by the Pukyong National University
Zitieren
APA
Truong, T. T., Singh, A. A., Tak, S., Na, S., Choi, J., Oh, J., & Mondal, S. (2025). Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer. Cells. https://doi.org/10.3390/cells14241948
Vancouver
Truong TT, Singh AA, Tak S, Na S, Choi J, Oh J, et al. Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer. Cells. 2025. doi:10.3390/cells14241948
BibTeX
@article{Truong2025,
author = {Truong, Thi Thuy and Singh, Alka Ashok and Tak, Soonhyuk and Na, Sungsoo and Choi, Jaeyeop and Oh, Junghwan and Mondal, Sudip},
title = {Plant-Derived Antioxidants as Modulators of Redox Signaling and Epigenetic Reprogramming in Cancer},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14241948}
}
EUVIMED